Eileen O Reilly
Tracked across 1 events · 74 articles · First seen May 29, 2026 · Last active Jun 04, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Eileen O Reilly, a pancreatic cancer specialist at Memorial Sloan Kettering Cancer Center, was the lead author of a paper detailing daraxonrasib's results, providing expert insight into the drug's efficacy and patient adherence.
May 29, 2026 · 74 articles
ERGEN INTELLIGENCE
Track Eileen O Reilly live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard